Dura mater is a potential source of Aβ seeds

Acta Neuropathologica

Volumn 131, Issue 6, 2016, Pages 911-923

  Kovacs, Gabor G ^a   Lutz, Mirjam I ^a   Ricken, Gerda ^a   Ströbel, Thomas ^a   Höftberger, Romana ^a   Preusser, Matthias ^a   Regelsberger, Günther ^a   Hönigschnabl, Selma ^b   Reiner, Angelika ^b   Fischer, Peter ^b   Budka, Herbert ^a,c   Hainfellner, Johannes A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b DANUBE HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Alzheimer disease; Amyloid ; Dura mater; Iatrogenic Creutzfeldt Jakob disease; Prion; Propagon

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; DURA MATER; FEMALE; HUMAN; HUMAN TISSUE; IATROGENIC CREUTZFELDT JAKOB DISEASE; MALE; MENTAL DETERIORATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TRAUMATIC BRAIN INJURY; VASCULAR AMYLOIDOSIS; BRAIN; CASE REPORT; CEREBRAL AMYLOID ANGIOPATHY; CREUTZFELDT-JAKOB SYNDROME; METABOLISM; PATHOLOGY; PRION DISEASES;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AUTOPSY; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; FEMALE; HUMANS; PRION DISEASES;

EID: 84961652540     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-016-1565-x     Document Type: Article

References (57)

1. Aho L, Pikkarainen M, Hiltunen M, Leinonen V, Alafuzoff I (2010) Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra- and intracellular compartments in the human brain. J Alzheimers Dis 20:1015–1028
2. Alafuzoff I, Thal DR, Arzberger T et al (2009) Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117:309–320
3. Andres KH (1967) On the fine structure of the arachnoidea and dura mater of mammals. Z Zellforsch Mikrosk Anat 79:272–295
4. Aspelund A, Antila S, Proulx ST et al (2015) A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 212:991–999
5. Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75–93
6. Bohl J, Storkel S, Steinmetz H (1989) Involvement of the central nervous system and its coverings in different forms of amyloidosis. Prog Clin Biol Res 317:1007–1019
7. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171–181
8. Braak H, Del Tredici K (2015) The preclinical phase of the pathological process underlying sporadic Alzheimer’s disease. Brain 138:2814–2833
9. Brettschneider J, Del Tredici K, Lee VM, Trojanowski JQ (2015) Spreading of pathology in neurodegenerative diseases: a focus on human studies. Nat Rev Neurosci 16:109–120
10. Carare RO, Hawkes CA, Jeffrey M, Kalaria RN, Weller RO (2013) Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol Appl Neurobiol 39:593–611
11. Chen XH, Johnson VE, Uryu K, Trojanowski JQ, Smith DH (2009) A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol 19:214–223
12. Cupidi C, Capobianco R, Goffredo D et al (2010) Neocortical variation of Abeta load in fully expressed, pure Alzheimer’s disease. J Alzheimers Dis 19:57–68
13. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer’s disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81:328–335
14. Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol 118:5–36
15. Eisele YS, Duyckaerts C (2016) Propagation of Aβ pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:5–25
16. Fischer P, Jungwirth S, Krampla W, et al. (2002) Vienna Transdanube Aging “VITA”: study design, recruitment strategies and level of participation. J Neural Transm Suppl 62:105–116
17. Földi M, Csanda E, Simon M et al (1968) Lymphogenic haemangiopathy. “Prelymphatic” pathways in the wall of cerebral and cervical blood vessels. Angiologica 5:250–262
18. Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H (2016) Amyloid-beta pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med Wkly 146:w14287
19. Ghoshal N, Cali I, Perrin RJ et al (2009) Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. Arch Neurol 66:1240–1246
20. Grinberg LT, Rub U, Ferretti RE et al (2009) The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer’s disease. A precocious onset? Neuropathol Appl Neurobiol 35:406–416
21. Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130–138
22. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
23. Horsburgh K, Cole GM, Yang F et al (2000) beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury. Neuropathol Appl Neurobiol 26:124–132
24. Irwin DJ, Abrams JY, Schonberger LB et al (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462–468
25. Jaunmuktane Z, Mead S, Ellis M et al (2015) Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy. Nature 525:247–250
26. Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W (2013) Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 136:28–42
27. Johnson VE, Stewart W, Smith DH (2010) Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer’s disease? Nat Rev Neurosci 11:361–370
28. Johnson VE, Stewart W, Smith DH (2012) Widespread tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol 22:142–149
29. Keable A, Fenna K, Yuen HM et al (2015) Deposition of amyloid beta in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy. Biochim Biophys Acta. doi:10.1016/j.bbadis.2015.08.024:
30. Kida S, Pantazis A, Weller RO (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 19:480–488
31. Kovacs GG (2016) Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine. Int J Mol Sci 17:189. doi:10.3390/ijms17020189
32. Kovacs GG, Budka H (2013) The spectrum of tau pathology in human prion disease. In: Zou W-Q, Gambetti P (eds) Prions and diseases. Springer, New York, pp 103–119
33. Kovacs GG, Horvath MC, Majtenyi K, Lutz MI, Hurd YL, Keller E (2015) Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions. Neurobiol Aging 36:3100–3107
34. Kovacs GG, Milenkovic I, Wohrer A et al (2013) Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol 126:365–384
35. Kovacs GG, Seguin J, Quadrio I et al (2011) Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol 121:39–57
36. Leclercq PD, Murray LS, Smith C, Graham DI, Nicoll JA, Gentleman SM (2005) Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype. J Neurol Neurosurg Psychiatry 76:229–233
37. Lewis J, Dickson DW (2016) Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:27–48
38. Louveau A, Smirnov I, Keyes TJ et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337–341
39. McKee AC, Cairns NJ, Dickson DW et al (2016) The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol 131:75–86
40. McKee AC, Stein TD, Kiernan PT, Alvarez VE (2015) The neuropathology of chronic traumatic encephalopathy. Brain Pathol 25:350–364
41. McKee AC, Stern RA, Nowinski CJ et al (2013) The spectrum of disease in chronic traumatic encephalopathy. Brain 136:43–64
42. Metsaars WP, Hauw JJ, van Welsem ME, Duyckaerts C (2003) A grading system of Alzheimer disease lesions in neocortical areas. Neurobiol Aging 24:563–572
43. Murakami T, Ishiguro N, Higuchi K (2014) Transmission of systemic AA amyloidosis in animals. Vet Pathol 51:363–371
44. Parchi P, de Boni L, Saverioni D et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517–529
45. Pletnikova O, Rudow GL, Hyde TM et al (2015) Alzheimer lesions in the autopsied brains of people 30 to 50 years of age. Cogn Behav Neurol 28:144–152
46. Preusser M, Ströbel T, Gelpi E et al (2006) Alzheimer-type neuropathology in a 28 year old patient with iatrogenic Creutzfeldt-Jakob disease after dural grafting. J Neurol Neurosurg Psychiatry 77:413–416
47. Reiniger L, Lukic A, Linehan J et al (2011) Tau, prions and Abeta: the triad of neurodegeneration. Acta Neuropathol 121:5–20
48. Roland J, Bernard C, Bracard S et al (1987) Microvascularization of the intracranial dura mater. Surg Radiol Anat 9:43–49
49. Scott G, Ramlackhansingh AF, Edison P et al (2016) Amyloid pathology and axonal injury after brain trauma. Neurology 86:821–828
50. Stratmann K, Heinsen H, Korf HW et al (2015) Precortical phase of Alzheimer’s disease (AD)-related tau cytoskeletal pathology. Brain Pathol. doi:10.1111/bpa.12289:
51. Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282–293
52. Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease. Acta Neuropathol 115:599–609
53. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800
54. Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner GG (1991) Re-examination of ex-boxers’ brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol 82:280–285
55. Uchihara T, Giasson BI (2016) Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:49–73
56. Uchihara T, Giasson BI, Paulus W (2016) Propagation of Abeta, tau and alpha-synuclein pathology between experimental models and human reality: prions, propagons and propaganda. Acta Neuropathol 131:1–3
57. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol 18:253–266